** = Publications listed in SCI/SSCI/Pubmed
** Habich, D; Horvath, A; Feldbacher, N; Rebol, L; Nepel, M; Madl, T; Habisch, HJ; Baumann-Durchschein, F; Fürst, S; Plank, J; Rainer, F; Spindelböck, W; Stauber, RE; Tatscher, E; Wagner, M; Zollner, G; Stadlbauer, V
An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study.
Clin Nutr. 2026; 56: 106522
Doi: 10.1016/j.clnu.2025.11.007
Web of Science
PubMed
FullText
FullText_MUG
** Horvath, A; Habich, D; Feldbacher, N; Celcer, L; Stadlbauer, V
L-ornithine-L-aspertate improves quality of life and ammonia levels but not microbiome dysbiosis in cirrhosis: results of a phase 4 study
J HEPATOL. 2025; 82: -European-Association-for-the-Study-of-the-Liver Congress; MAY 07-10, 2025; Amsterdam, NETHERLANDS.
[Poster]
Web of Science